CE-326,597

CE-326,597 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CE-326,597, covering 2010-01-18 to 2012-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight [Phase 2]